INTERNATIONAL PATENT: REGENERON PHARMACEUTICALS, INC. FILES APPLICATION FOR "THERAPEUTIC STRATEGIES TO REDUCE THROMBOTIC RISK IN FACTOR V LEIDEN (FVL) CARRIERS"

GENEVA, Feb. 24 -- REGENERON PHARMACEUTICALS, INC. (777 Old Saw Mill River RoadTarrytown, New York 10591) filed a patent application (PCT/US2025/042156) for "THERAPEUTIC STRATEGIES TO REDUCE THROMBOTIC RISK IN FACTOR V LEIDEN (FVL) CARRIERS" on Aug 15, 2025. With publication no. WO/2026/039728, the details related to the patent application was published on Feb 19, 2026.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): DE, Tanima (777 Old Saw Mill River RoadTarrytown, New York 10591), CHALOTHORN, Dan (777 Old Saw Mill River RoadTarrytown, New York 10591), LAI, KehDih (777 Old Saw Mill River RoadTarr...